JP2016513953A5 - - Google Patents

Download PDF

Info

Publication number
JP2016513953A5
JP2016513953A5 JP2015556448A JP2015556448A JP2016513953A5 JP 2016513953 A5 JP2016513953 A5 JP 2016513953A5 JP 2015556448 A JP2015556448 A JP 2015556448A JP 2015556448 A JP2015556448 A JP 2015556448A JP 2016513953 A5 JP2016513953 A5 JP 2016513953A5
Authority
JP
Japan
Prior art keywords
idc
antigen
cells
vector
cytokine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015556448A
Other languages
English (en)
Japanese (ja)
Other versions
JP6866988B2 (ja
JP2016513953A (ja
Filing date
Publication date
Priority claimed from PCT/EP2013/052485 external-priority patent/WO2014121840A1/en
Application filed filed Critical
Publication of JP2016513953A publication Critical patent/JP2016513953A/ja
Publication of JP2016513953A5 publication Critical patent/JP2016513953A5/ja
Application granted granted Critical
Publication of JP6866988B2 publication Critical patent/JP6866988B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015556448A 2013-02-07 2014-01-24 誘導された樹状細胞およびその使用 Expired - Fee Related JP6866988B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP2013/052485 WO2014121840A1 (en) 2013-02-07 2013-02-07 Induced dendritic cells and uses thereof
EPPCT/EP2013/052485 2013-02-07
PCT/EP2014/051422 WO2014122035A2 (en) 2013-02-07 2014-01-24 Induced dendritic cells and uses thereof

Publications (3)

Publication Number Publication Date
JP2016513953A JP2016513953A (ja) 2016-05-19
JP2016513953A5 true JP2016513953A5 (enExample) 2017-03-02
JP6866988B2 JP6866988B2 (ja) 2021-04-28

Family

ID=47664310

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015556448A Expired - Fee Related JP6866988B2 (ja) 2013-02-07 2014-01-24 誘導された樹状細胞およびその使用

Country Status (5)

Country Link
US (2) US10272111B2 (enExample)
JP (1) JP6866988B2 (enExample)
CN (1) CN105025924A (enExample)
CA (1) CA2899786C (enExample)
WO (2) WO2014121840A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105039256A (zh) * 2015-07-13 2015-11-11 中政道和（北京）生物科技有限公司 一种支气管镜下获取肿瘤组织进行树突细胞培养扩增方法
ES2964746T3 (es) * 2015-12-30 2024-04-09 Celgene Corp Métodos de producción de linfocitos T y linfocitos T producidos mediante el mismo
US11464805B2 (en) * 2016-12-21 2022-10-11 University Of Florida Research Foundation, Incorporated CCR2+ hematopoietic stem cells mediate T cell activation in adoptive cell therapy
US20200208108A1 (en) * 2017-05-10 2020-07-02 Aarhus Universitet Interferon primed plasmacytoid dendritic cells
JP7290288B2 (ja) * 2017-08-22 2023-06-13 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 免疫不全及び自己免疫疾患を治療するための、造血幹細胞でｆｏｘｐ３を発現するレンチウイルスベクター
BR112021000620A2 (pt) 2018-07-15 2021-04-20 Enochian BioPharma, Inc. métodos e composições com uso de células dendríticas recombinantes para terapia contra câncer
US10980836B1 (en) * 2019-12-11 2021-04-20 Myeloid Therapeutics, Inc. Therapeutic cell compositions and methods of manufacturing and use thereof
KR20220143642A (ko) * 2019-12-11 2022-10-25 마이얼로이드 테라퓨틱스, 인크. 치료 세포 조성물 및 그의 제조 방법 및 용도
EP4157989A4 (en) * 2020-05-28 2024-06-26 Biomagnetic Solutions LLC COMPOSITIONS AND METHODS FOR NEGATIVE SELECTION OF NATIVE T AND B CELLS WITH A SINGLE ANTIBODY
CN111647563A (zh) * 2020-08-06 2020-09-11 北京翊博普惠生物科技发展有限公司 靶向Survivin全抗原的DC细胞、CTL细胞及其制备方法和应用
US20240002798A1 (en) * 2020-11-17 2024-01-04 Research & Business Foundation Sungkyunkwan University Method for preparing immunogenicity-enhanced cd103+ fcgr3+ dendritic cell by treatment with interleukin-33 and pharmaceutical composition comprising same dendritic cell for cancer immunotherapy
CA3212398A1 (en) 2021-03-17 2022-09-22 Daniel Getts Engineered chimeric fusion protein compositions and methods of use thereof
CA3218780A1 (en) 2021-05-11 2022-11-17 Daniel Getts Methods and compositions for genomic integration
CN113881631B (zh) * 2021-10-11 2022-08-02 北京翊博普惠生物科技发展有限公司 一种扁桃体来源的Tγδ细胞及其制备方法和应用
CN117625531A (zh) * 2022-08-30 2024-03-01 浙江吉量科技有限公司 树突细胞祖细胞的制备方法及其培养基

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011002727A1 (en) * 2009-06-29 2011-01-06 Qingfeng Chen Methods of producing humanized non-human mammals
DE102012207453B4 (de) 2012-05-04 2017-10-19 Technische Universität Dresden Humanisierte Mäuse ohne Konditionierung

Similar Documents

Publication Publication Date Title
JP2016513953A5 (enExample)
WO2016018920A8 (en) Il-15 and il-15ralpha heterodimer dose escalation regimens for treating conditions
EP4269601A3 (en) Modified t cells and methods of making and using the same
EA201991692A1 (ru) Иммуносконструированные плюрипотентные клетки
EA201390681A1 (ru) Производные полипептиды il-2 с агонистической активностью для лечения рака и хронических инфекций
HK1225226A1 (zh) 选择性胚胎结构靶向和物质递送装置
MY157564A (en) Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract
EP3153523A3 (en) Variants of prothymosin alpha and methods of using same
JP2014513722A5 (enExample)
PH12015502844A1 (en) Mammalian milk osteopontin for enhancing immune responsiveness
EP4549546A3 (en) Dendritic cell generator
WO2015140172A3 (en) A medicament for use in a method of inducing or extending a cellular cytotoxic immune response
IL286629A (en) Multi-respiratory virus antigen-specific t cells and methods of making and using the same therapeutically
EP4252742A3 (en) Fluticasone furoate in the treatment of copd
WO2016159582A3 (ko) 형개 추출물을 유효성분으로 함유하는 선천면역 증진 및 항바이러스용 조성물
MX2017002841A (es) Metodos para tratar enfermedades autoinmunes con el uso de un anticuerpo de dominio dirigido contra cd40l.
EP4282485A3 (en) Dosage regimen for pegylated interferon
Zakirova et al. Case of applying allogenic mesenchymal stem cells of adipogenic origin in veterinary dentistry
FI3144002T3 (fi) Granulosyytti-makrofagikasvutekijää (GM-CSF) tuottava T-solusäätelyaine sekä Th1/Th2-immuunitasapainon säätelijä
De Pijper et al. WHO bites back rabies pre-travel vaccination schedules-Implications for travel medicine
WO2016159583A3 (ko) 지구자 추출물을 유효성분으로 함유하는 선천면역 증진 및 항바이러스용 조성물
RU2015157320A (ru) Способ профилактики вирусных болезней птиц
WO2015130488A3 (en) Mhc class i associated peptides for prevention and treatment of hepatitis b virus infection
JP2018043942A5 (enExample)
WO2015189711A3 (en) Veterinary composition and method of improving livability of animals, promoting live weight gain in mammals and birds, enhancing the effectiveness of immunization, and preventing and/or treating infectious diseases (variants)